Feasibility Study to Assess the Scan, Fit and Print Process for the Aveera "Patient Matched" CPAP Mask

NCT ID: NCT02972970

Last Updated: 2017-06-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-10-31

Study Completion Date

2017-05-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Feasibility study to assess the scan, fit and print process for the Aveera "Patient Matched" CPAP Mask

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Assess the process of scan, fit and print
2. Subjective/objective assessment of fit of the Aveera during the 2 week use for leaks and comfort
3. Ethnographic insights into the user experience of the scan, fit, print process.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aveera

This is a prospective, open label study to assess the scan, print and fit process to see if the Aveera will be able to be used with conventional CPAP therapy devices

Group Type OTHER

Aveera

Intervention Type DEVICE

Subjects will use the 3D crafted CPAP mask. All subjects will receive a mask to use

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aveera

Subjects will use the 3D crafted CPAP mask. All subjects will receive a mask to use

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 18 years of age
* Both genders
* Currently prescribed fixed pressure CPAP or APAP for the treatment of OSA
* Currently CPAP pillows and nasal mask users
* Patients who are adherent as defined by conventional standards (i.e. 4 hours per night/70% of the nights)

Exclusion Criteria

* Unwilling to wear the AVEERA
* Concern about privacy of data
* Pregnant
* Full face mask user
* Any medical condition deemed by the investigator to pose an issue with the subject's participation.
* Upper limit of CPAP pressure of ≥ to 15 cm H20 or APAP a upper limit pressure setting of ≥17cm H2O
* Requires the use of supplemental oxygen
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Metamason

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

robyn woidtke

Role: STUDY_DIRECTOR

Consultant

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tower Sleep Medicine

Los Angeles, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Meta-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Amara View Benchmark Study
NCT06535932 COMPLETED NA
AirSense 10 AHI Validation Study
NCT03043703 WITHDRAWN NA